SCHEMBL4619610

SCHEMBL4619610

CC(=O)NCCNS(=O)(=O)c1cccc(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.53
KMT2A Q03164 2/20 0.51
USP2 O75604 1/20 0.51
SFRP1 Q8N474 2/20 0.48
AKR1C3 P42330 3/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 2/20 0.47
ATM Q13315 1/20 0.47
POLB P06746 1/20 0.46
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28952726 0.87 USP2 (0.64) MAPK1KMT2AUSP2ALDH1A1POLB
SCHEMBL4617937 0.81 ATM (0.69) KMT2ASFRP1AKR1C3CYP2C19ALDH1A1
SCHEMBL4616985 0.80 ALDH1A1 (0.56) MAPK1KMT2ASFRP1AKR1C3CYP2C19
SCHEMBL4617581 0.79 ATM (0.55) KMT2ASFRP1AKR1C3CYP2C19ALDH1A1
SCHEMBL19334360 0.78 KMT2A (0.58) MAPK1KMT2AUSP2CYP2C19ALDH1A1
SCHEMBL28770814 0.77 LMNA (0.53) KMT2ASFRP1ALDH1A1KDM4EMEN1
SCHEMBL4618261 0.77 SFRP1 (0.62) KMT2ASFRP1ALDH1A1ATMKDM4E
SCHEMBL4617091 0.77 MAPK1 (0.61) MAPK1KMT2ASFRP1ALDH1A1POLB
SCHEMBL4616767 0.77 ALDH1A1 (0.71) SFRP1AKR1C3ALDH1A1POLBHDAC2
SCHEMBL18995906 0.76 CYP2C19 (0.67) KMT2AAKR1C3CYP2C19ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 MAPK1 934/4885KMT2A 3832/4885USP2 2796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.